James Zhang is involved in investments in a variety of sectors for the medical care industry, including medicine, diagnostic reagents, and medical instruments. Jianbin also has expertise in new drug developments, medicine sales channels, medicine marketing, and enterprise management. He received an MBA from Cheung Kong Graduate School and holds a bachelor’s degree in Engineering from the Nanjing University of Chemical Engineering. Jianbin is also a Licensed Pharmacist.

James Zhao has a total of 21 years of experience in the healthcare industry, of which, prior to founding LYFE Capital, he was at Vivo Capital for 8 years. Initially trained in clinical medicine, he attained his MBA from Olin school of Business. James is based out of LYFE Capital’s Shanghai and Menlo Park offices.

Founded in 2015, LYFE Capital is a dedicated healthcare fund that has successfully raised $720 million and is currently deploying out of our 2017 vintage year, $420 million fund. LYFE Capital is actively seeking healthcare companies with exceptional management teams and vision in the Sino-American markets, focusing on growth and innovation stages. LYFE Capital’s investment focus spans biopharmaceuticals; medical devices; life science tools and diagnostics; animal health; and healthcare services. LYFE Capital works closely with its portfolio companies to support their needs by not only providing capital but with active support in global expansion, global partnerships, market planning, and talent acquisition. LYFE doesn’t see our portfolio companies as just investments, but rather partners.